United States Anti-Doping Agency Reauthorization Act of 2021

3/8/2023, 7:58 PM

United States Anti-Doping Agency Reauthorization Act of 2021

This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030.

The bill adds requirements that USADA

  • be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and
  • promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports.

The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection.

The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

Bill 117 HR 172, also known as the United States Anti-Doping Agency Reauthorization Act of 2021, is a piece of legislation that aims to reauthorize and provide funding for the United States Anti-Doping Agency (USADA). The USADA is responsible for overseeing drug testing and anti-doping efforts in Olympic and Paralympic sports in the United States.

The bill includes provisions to ensure that the USADA has the necessary resources to continue its important work in promoting clean and fair competition in sports. This includes funding for drug testing programs, education and outreach efforts, and research into new methods of detecting performance-enhancing substances.

Additionally, the bill includes measures to improve transparency and accountability within the USADA. This includes requirements for the agency to report regularly to Congress on its activities and finances, as well as provisions to ensure that athletes have access to a fair and impartial appeals process in cases of alleged doping violations. Overall, the United States Anti-Doping Agency Reauthorization Act of 2021 aims to support the USADA in its mission to protect the integrity of sports and ensure a level playing field for all athletes.
Congress
117

Number
HR - 172

Introduced on
2021-01-04

# Amendments
0

Sponsors
+5

Cosponsors
+5

Variations and Revisions

4/15/2021

Status of Legislation

Bill Introduced
Introduced to House
Passed in House
Introduced to Senate
Senate to Vote

Purpose and Summary

United States Anti-Doping Agency Reauthorization Act of 2021

This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030.

The bill adds requirements that USADA

  • be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and
  • promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports.

The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection.

The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

Bill 117 HR 172, also known as the United States Anti-Doping Agency Reauthorization Act of 2021, is a piece of legislation that aims to reauthorize and provide funding for the United States Anti-Doping Agency (USADA). The USADA is responsible for overseeing drug testing and anti-doping efforts in Olympic and Paralympic sports in the United States.

The bill includes provisions to ensure that the USADA has the necessary resources to continue its important work in promoting clean and fair competition in sports. This includes funding for drug testing programs, education and outreach efforts, and research into new methods of detecting performance-enhancing substances.

Additionally, the bill includes measures to improve transparency and accountability within the USADA. This includes requirements for the agency to report regularly to Congress on its activities and finances, as well as provisions to ensure that athletes have access to a fair and impartial appeals process in cases of alleged doping violations. Overall, the United States Anti-Doping Agency Reauthorization Act of 2021 aims to support the USADA in its mission to protect the integrity of sports and ensure a level playing field for all athletes.
Alternative Names
Official Title as IntroducedTo reauthorize the United States Anti-Doping Agency, and for other purposes.

Policy Areas
Sports and Recreation

Potential Impact
Alternative dispute resolution, mediation, arbitration•
Athletes•
Child health•
Congressional oversight•
Criminal investigation, prosecution, interrogation•
Drug safety, medical device, and laboratory regulation•
Drug, alcohol, tobacco use•
Due process and equal protection•
International law and treaties•
International organizations and cooperation•
Medical tests and diagnostic methods•
Olympic games

Comments

Recent Activity

Latest Summary4/22/2021

United States Anti-Doping Agency Reauthorization Act of 2021

This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030.

The bill adds requirements that USADA

  • be responsi...

Latest Action4/15/2021
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.